Executive Board
The Executive Board has been established to assist the Chief Executive in leading The Institute of Cancer Research to achieve its strategic aims and objectives within the approved strategies and budgets and is responsible for formulating strategies, plans and budgets for approval by the Board of Trustees.
Professor Kristian Helin
Chief Executive and President
Carol Ford
Chief People Officer
Professor Kevin Harrington
Head of Division – Radiotherapy and Imaging
Professor Clare Isacke
Dean of Academic & Research Affairs
Paul Norris
Chief Financial Officer
Professor Jonathon Pines
Head of Division – Cancer Biology
Dr Barbara Pittam
Chief Research and Academic Officer
Dr Olivia Rossanese
Head of Division and Director – Cancer Therapeutics
Latest ICR News
New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment
Researchers have developed a new tool that could help clinicians diagnose the most common type of breast cancer more accurately and make better treatment decisions.
Scientists show that the immune system indirectly influences the genes that drive cancer
Researchers have uncovered new details about the complex relationship between the immune system and cancer.
Breast cancer risk model provides reassuring data for those with family history of disease after short-term HRT use
Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk model published in the British Journal of General Practice.
Neoadjuvant radiotherapy may hamper immunotherapy, new breast cancer research finds
A new study has provided novel insights into the effects of radiation on the immune cells surrounding breast cancer tumours.